全文获取类型
收费全文 | 19136篇 |
免费 | 1099篇 |
国内免费 | 1695篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 219篇 |
妇产科学 | 187篇 |
基础医学 | 2519篇 |
口腔科学 | 41篇 |
临床医学 | 1571篇 |
内科学 | 7929篇 |
皮肤病学 | 38篇 |
神经病学 | 48篇 |
特种医学 | 149篇 |
外科学 | 726篇 |
综合类 | 2777篇 |
预防医学 | 3697篇 |
眼科学 | 8篇 |
药学 | 1313篇 |
11篇 | |
中国医学 | 285篇 |
肿瘤学 | 404篇 |
出版年
2023年 | 130篇 |
2022年 | 391篇 |
2021年 | 541篇 |
2020年 | 462篇 |
2019年 | 471篇 |
2018年 | 472篇 |
2017年 | 406篇 |
2016年 | 642篇 |
2015年 | 821篇 |
2014年 | 1348篇 |
2013年 | 1272篇 |
2012年 | 1368篇 |
2011年 | 1588篇 |
2010年 | 1297篇 |
2009年 | 1264篇 |
2008年 | 1093篇 |
2007年 | 1280篇 |
2006年 | 1114篇 |
2005年 | 1022篇 |
2004年 | 701篇 |
2003年 | 605篇 |
2002年 | 558篇 |
2001年 | 490篇 |
2000年 | 418篇 |
1999年 | 407篇 |
1998年 | 312篇 |
1997年 | 286篇 |
1996年 | 166篇 |
1995年 | 214篇 |
1994年 | 197篇 |
1993年 | 90篇 |
1992年 | 89篇 |
1991年 | 50篇 |
1990年 | 59篇 |
1989年 | 51篇 |
1988年 | 48篇 |
1987年 | 40篇 |
1986年 | 37篇 |
1985年 | 28篇 |
1984年 | 15篇 |
1983年 | 10篇 |
1982年 | 7篇 |
1981年 | 10篇 |
1980年 | 7篇 |
1979年 | 9篇 |
1978年 | 8篇 |
1977年 | 6篇 |
1976年 | 5篇 |
1974年 | 5篇 |
1972年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
乙型肝炎病毒前S1抗原检测及其临床意义 总被引:10,自引:0,他引:10
为探讨检测乙型肝炎病毒前S1抗原(Pre-S1Ag)的临床意义,本文对338例各型乙型肝炎患者进行Pre-S1Ag检测,同时检测HBV标志物和HBV-DNA,对其阳性率及相互关系进行分析比较.结果表明:338例患者,Pre-S1Ag阳性检测率为63.02%,HBeAg阳性检测率为48.52%,HBV-DNA阳性检测率为68.05%.Pre-S1Ag阳性与HBV-DNA阳性的符合率为78.56%;Pre-S1Ag与HBeAg阳性的符合率为81.17%;Pre-S1Ag与HBeAg、HBV-DNA具有显著相关性(P<0.01),提示Pre-S1Ag能够较好地反映病毒复制状况,有可能作为体内病毒复制存在的实验室指标. 相似文献
132.
丙型肝炎病毒基因分型及其与疾病程度、感染途径和干扰素疗效的关系 总被引:9,自引:0,他引:9
为探讨广州地区丙型肝炎病毒(HCV)感染的基因型及其与疾病程度、感染途径和干扰素疗效的关系,作者应用分型PCR技术对156例抗-HCV阳性患者血清HCVRNA进行分型检测,并分析不同程度肝病及不同感染途径HCV基因型分布,且对51例经干扰素治疗的慢性丙肝作分型评价。结果124例HCVRNA阳性中,Ⅱ型占90.3%(112例),Ⅲ型占8.1%(10例),Ⅱ/Ⅲ型混合感染占1.6%(2例),未检出Ⅰ、Ⅳ型,说明广州地区HCV感染以Ⅱ型为主;不同程度肝病及不同感染途径之间HCV基因型构成比无明显差异,表明基因型与疾病严重程度及感染途径关系不大;干扰素治疗病例,HCV-Ⅱ、Ⅲ型感染的总应答数、完全应答数及部分应答数分别为18/41,11/41,7/41和8/10,6/10,2/10,提示Ⅲ型感染疗效较好,HCV基因型似可作为选择干扰素治疗病例及判断疗效的参考指标,但是由于观察的Ⅲ型病例数较少,需积累更多的资料才能作出更客观的结论。 相似文献
133.
利用重组的丙型肝炎病毒非结构区(HCVNS5)抗原建立了酶免疫试验(EIA),对25例输血后丙型肝炎进行了不同区抗体及丙氨酸转氨酶(ALT)的动态研究,同时对156例慢性丙型肝炎患者血清进行HCVRNA和抗-NS5平行检测,两者符合率为64.1%。抗-NS5抗体首次检出时间为30~575天(182.9±168.5),晚于ALT异常和其他区抗体的出现时间。在感染后1,3,6,12和24个月后抗-NS5的阳性率分别为28%,40%,52%,68%和76%。抗-NS5的动态变化类型为四种:一过性阳性、间歇性阳性、持续性阳性和2年内持续阴性 相似文献
134.
Objective To investigate the level of the serum chemokine RANTES and its correlation with serum biochemical indices of liver function test, HBeAg and HBV DNA load in patients with chronic hepatitis B.Methods 144 patients with chronic hepatitis B (observed group) and 18 normal cases (control group) were enrolled in this study. The serum level of chemokine RANTES was detected with an ABC-ELISA assay. Statistical analysis was performed on the software of SPSS13.0. Results The serum chemokine RANTES level in the observed group (3930.12 ng/ml±2856.96) ng/ml was significantly higher than that in the control group (329.46 ng/ml±152.23) ng/ml. The results from the observed group indicated the positive correlation of serum RANTES level with indices of liver function test, including ALT (r=0. 197, P=0.018), AST(r=0.239, P=0.004) and TBil (r=0.316, P=0.001), but did not with PTA (r=-0.078, P=0.357). Neither difference of serum chemokine RANTES level between HBeAg-positive group and HBeAg-negative group nor that between high HBV DNA load group (≥105 copies/ml) and low HBV DNA load group (< 105 copies/ml) were statistically significant (P=0.407 and 0.185, respectively). Conclusions Serum chemokine RANTES level in patients with chronic hepatitis B elevates significantly and is not affected by HBeAg or HBV DNA load. Its positive correlation with indices of liver function test indicates that RANTES might play an important rule in the pathogenesis of chronic hepatitis B. 相似文献
135.
目的 了解我国女性输血后丙型肝炎病毒 (HCV)感染的慢性化规律和影响因素。方法 对河北省固安县 1989~ 1993年 4 1例女性慢性输血后丙型肝炎患者的现状进行调查 ,包括临床表现 ,血清生物化学指标 ,病毒学标志检测及B型超声检查。其中 ,HCVRNA的测定采用荧光定量PCR方法 ,抗 HIV ,抗 HCV和HBsAg测定采用酶联免疫吸附试验。结果 4 1例女性丙型肝炎患者平均年龄 (40± 7)岁 ,随访时间 10~ 15年 ,HCVRNA间隔半年两次检测 ,自然阴转率为 19 5 1% (8 4 1)。 30例(73% )现在有症状 ,以乏力最为常见 (77% )。总的丙氨酸转氨酶 (ALT)和 (或 )天冬氨酸转氨酶 (AST)异常率为 32 % (13 4 1) ,均为轻度异常 ,无中度和重度。B超轻度慢性肝炎占 83% (34 4 1) ,中度占 17%(7 4 1) ,无重度。结论 平均感染 (13± 1)年的女性输血后慢性丙型肝炎患者多数肝脏炎症轻微慢性感染进程中有部分感染者出现HCVRNA自发阴转。 相似文献
136.
目的 探讨血清HCV RNA检测在预防输血后丙型肝炎中的意义。方法 用ELISA法检测2000年1月至2003年12月末抗.HCV阴性的全血标本56400份次,再进行RT-PCR(荧光适时技术)检测HCV RNA,并对输过HCV RNA筛查阴性血液的患者进行追查。结果 HCVRNA阳性率为2.5‰(146/56400)。对输过HCVRNA筛查阴性血液的患者追查结果,无一例发生输血后丙型肝炎。结论 对抗-HCV阴性的血液标本用敏感的试剂进行HCV RNA检测在预防输血后丙型肝炎中不但有效,而且可行。 相似文献
137.
Yide Jin Laphalle Fuller Manuel Carreno Keith Zucker David Roth Violet Esquenazi Theodore Karatzas Sidney J. Swanson III Andreas G. Tzakis Joshua Miller 《Journal of clinical immunology》1997,17(2):140-153
Liver infiltrating lymphocytes (LIL) were isolated from HCV-positive (+) and HCV-negative (–) end-stage livers. Phenotypic analysis and functional studies using proliferative and lymphocytotoxic assays were performed with the isolated LIL. Two CD3+ lymphocyte populations were found in LIL using FITC anti-CD3 monoclonal antibodies (mAb). One was a bright fluorescence intensity population (as in PBL), and the other dim. We calculated the number of FITC-anti-CD3 mAbs bound per lymphocyte on PBL and LIL and found 80,040 ± 4628 and 39,615 ± 3932, respectively. Therefore, HCV+ and HCV– patient PBL contained approximately twice the number of CD3 molecules per cell than patient CD3+ LIL. LIL also contained approximately a threefold higher concentration of TCR+, CD4–CD8–, and CD56,16 (NK) cells than the patient PBL. Thus, a major subset of LIL is phenotypically similar to mouse NK1.1+ intermediate T cells. LIL freshly isolated from HCV+ livers exhibited weak CTL activity against EBV- or Con A-transformed lymphoblast targets infected with vaccinia–HCV recombinant virus (rHCV) or primary hepatocyte cultured cells. However, after in vitro coculture of LIL with rHCV, these cells developed a strong cytotoxicity for the above targets. In contrast, LIL from HCV– livers were not cytotoxic against the same targets. Histochemical studies (in situ) demonstrated that these hepatocytes express CD95, and stains demonstrated apoptosis. The HCV+ hepatocytes also express class I MHC molecules and ICAM-1. The addition of mAb specific for these adhesion molecules inhibited CML activity. Short-term cultured hepatocytes (targets) from HCV+ and HCV– patients produced low levels of cytokines IL-1, IL-2, IL-6, TNF, and IFN- but a high level of IL-8. It is speculated that LIL expressing reduced numbers of CD3 molecules may even function as immune regulators as proposed for intermediate T cells in mice. 相似文献
138.
重型乙型病毒性肝炎肝组织内T淋巴细胞亚群的观察 总被引:1,自引:0,他引:1
本文用抗CD_3,CD_4,CD_8McAb和ABC法检测21例重型乙肝患者肝大片,亚大片坏死区炎性浸润细胞中的T细胞亚群,CD_3~+细胞>70%,其中主要为CD_8~+细胞,CD_4~+细胞减少,CD_4~+/CD_8~+比值显著下降,与急黄肝和慢活肝比较差异显著。相反,非HBV感染性肝病患者非T细胞和CD_4~+细胞增加,CD_4~+/CD_8~+比值>1。提示重肝时T细胞可能参与了肝损伤,CD_8细胞亚群可能是介导肝细胞坏死的重要因素之一。还观察到相当数量的淋巴细胞和肝细胞HLA—DR抗原阳性,淋巴细胞与膜型HBAg(+)肝细胞密切接触。 相似文献
139.
利用丙型肝炎病毒(HCV)5’-端序列合成两对引物,建立了灵敏、特异的HCVRNA双扩增聚合酶链反应检测方法。用此方法及第二代Abbott酶联抗-HCV检测试剂盒,检测了44例非甲非乙型肝炎患者血清及10名抗-HCV阴性健康人。在44例患者中,41例(93%)HCVRNA阳性,36例(82%)抗-HCV阳性,33例(75%)HCVRNA、抗-HCV全部阳性。3例HCVRNA阴性,但抗-HCV阳性,另外,有8例抗-HCV阴性,HCVRNA阳性。10名健康人HCVRNA均为阴性。结果表明,大部分(92%)抗-HCV阳性患者带有HCV,但为了检测所有病毒血症患者,抗-HCV检测是不够的,利用双扩增PCR方法检测HCVRNA对于抗-HCV阴性患者的诊断是非常有用的。 相似文献
140.
M. Heberer H. Talke K. P. Maier Prof. Dr. W. Gerok 《Journal of molecular medicine (Berlin, Germany)》1980,58(21):1189-1196
Summary 1. Amethod for the determination of phenylalaninehydroxylase-activity in needle biopsy material of human liver was developed and tested. The kinetic data of the enzyme were determined. TheK
m for the substrate phenylalanine is 1,32 mM, for the cofactor 0,08 mM.2. The activity of phenylalaninehydroxylase was determined in biopsies from normal liver, liver cirrhosis, alcoholic hepatitis and other liver diseases. In all liver diseases the enzyme activity related to wet weight or DNA is reduced. The capacity for the hydroxylation of phenylalanine (of a cirrhotic liver) amounts to about 20% of normal liver.3. After an oral load with L-phenylalanine (100 mg/kg) the phenylalanine- and tyrosine-concentration in blood plasma was followed for 5 hours. Patients with liver cirrhosis or acute hepatitis show significant higher concentrations of phenylalanine, and significant lower concentrations of tyrosine than normal persons.4. From the decline of phenylalanine-concentration after the maximum the phenylalanine-elimination rate and from the increase of tyrosine concentration the tyrosine-production rate were calculated. Between phenylalanine-elimination rate and tyrosine-production rate a strong correlation exists. In patients with cirrhosis or acute hepatitis significantly reduced phenylalanine-elimination rate and tyrosine production rate were found compared with persons without liver disease. Patients with alcoholi hepatitis show no significant difference compared with normal persons.5. There is no correlation between the activity of phenylalaninehydroxylase in liver tissue and phenylalanine-elimination rate and tyrosine-production rate, respectively, calculated from the concentration of this amino acids in serum after a phenylalanine load.6. We conclude from these findings that the increased serum concentration of phenylalanine in some liver diseases, especially liver cirrhosis, can partly be explained by the diminished metabolism of phenylalanine in the liver. Portocaval shunts probably contribute to the elevated level of phenylalanine in serum.Mit Unterstützung der Deutschen Forschungsgemeinschaft und der Sandoz-Stiftung für medizinische Forschung 相似文献